<DOC>
	<DOCNO>NCT00706680</DOCNO>
	<brief_summary>This study design test whether use Thymoglobulin low dose Cyclosporine early steroid dosage reduction minimize kidney rejection development new onset diabetes mellitus renal transplant .</brief_summary>
	<brief_title>Thymoglobulin Calcineurin Inhibitor Steroid Minimization Protocol</brief_title>
	<detailed_description>All patient receive methyl prednisone intravenously pre-operatively , per institutional practice . Thymoglobulin initiate prior completion anastomosis , possible , within 24 hour transplantation patient total dose 6-7.5mg/kg give 3-5 dos . Steroids initiate post-operatively 1mg/kg/day 2 day , 0.5mg/kg/day 2 day , 0.25mg/kg/day 2 day patient place 5mg daily remainder study . All patient receive Mycophenolic acid dose 2gm/day ( Cellcept ) 1440mg/day ( Myfortic ) post-transplantation dose adjustment need . Cyclosporine micro-emulsion initiate renal function establish later day 10 dose 3mg/kg twice daily adjustment achieve C2 target 600-800 nanograms/ml .</detailed_description>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>De Novo , single Kidney recipient At least 1 HLA mismatch Recipient multiple organ prior transplant recipient Subjects Diabetes prior transplant , indicate pretransplant OGTT PRA &gt; 10 % Hepatitis B surface antigen positive Hepatitis C antibody positive HIV positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>